Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.

Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE.

Mol Pharm. 2008 Jul-Aug;5(4):487-95. doi: 10.1021/mp800032f. Epub 2008 May 30. Review.

2.

Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking.

Duan X, Li Y.

Small. 2013 May 27;9(9-10):1521-32. doi: 10.1002/smll.201201390. Epub 2012 Sep 28. Review.

PMID:
23019091
3.

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE.

Adv Drug Deliv Rev. 2009 Jun 21;61(6):428-37. doi: 10.1016/j.addr.2009.03.009. Epub 2009 Apr 17. Review.

4.

Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures.

Murugan K, Choonara YE, Kumar P, Bijukumar D, du Toit LC, Pillay V.

Int J Nanomedicine. 2015 Mar 18;10:2191-206. doi: 10.2147/IJN.S75615. eCollection 2015. Review.

5.

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

Alexis F, Pridgen E, Molnar LK, Farokhzad OC.

Mol Pharm. 2008 Jul-Aug;5(4):505-15. doi: 10.1021/mp800051m. Epub 2008 Aug 4. Review.

6.

Current understanding of interactions between nanoparticles and the immune system.

Dobrovolskaia MA, Shurin M, Shvedova AA.

Toxicol Appl Pharmacol. 2016 May 15;299:78-89. doi: 10.1016/j.taap.2015.12.022. Epub 2015 Dec 29. Review.

7.

Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.

Ilinskaya AN, Dobrovolskaia MA.

Nanomedicine (Lond). 2013 May;8(5):773-84. doi: 10.2217/nnm.13.48. Review.

PMID:
23656264
8.

Immunosuppressive and anti-inflammatory properties of engineered nanomaterials.

Ilinskaya AN, Dobrovolskaia MA.

Br J Pharmacol. 2014 Sep;171(17):3988-4000. doi: 10.1111/bph.12722. Epub 2014 Jul 2. Review.

9.

The importance of nanoparticle shape in cancer drug delivery.

Truong NP, Whittaker MR, Mak CW, Davis TP.

Expert Opin Drug Deliv. 2015 Jan;12(1):129-42. doi: 10.1517/17425247.2014.950564. Epub 2014 Aug 20. Review.

PMID:
25138827
10.

Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems.

Karmali PP, Simberg D.

Expert Opin Drug Deliv. 2011 Mar;8(3):343-57. doi: 10.1517/17425247.2011.554818. Epub 2011 Feb 4. Review.

PMID:
21291354
11.
12.

Nanoparticles and the immune system.

Zolnik BS, González-Fernández A, Sadrieh N, Dobrovolskaia MA.

Endocrinology. 2010 Feb;151(2):458-65. doi: 10.1210/en.2009-1082. Epub 2009 Dec 16. Review.

13.

Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery.

Huang RB, Mocherla S, Heslinga MJ, Charoenphol P, Eniola-Adefeso O.

Mol Membr Biol. 2010 Oct;27(7):312-27. doi: 10.3109/09687688.2010.522117. Review.

PMID:
21028938
14.

Influence of nanoparticle shape, size, and surface functionalization on cellular uptake.

Ma N, Ma C, Li C, Wang T, Tang Y, Wang H, Moul X, Chen Z, Hel N.

J Nanosci Nanotechnol. 2013 Oct;13(10):6485-98. Review.

PMID:
24245105
15.

The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction.

Hoshyar N, Gray S, Han H, Bao G.

Nanomedicine (Lond). 2016 Mar;11(6):673-92. doi: 10.2217/nnm.16.5. Epub 2016 Mar 22. Review.

PMID:
27003448
16.

Physical Principles of Nanoparticle Cellular Endocytosis.

Zhang S, Gao H, Bao G.

ACS Nano. 2015 Sep 22;9(9):8655-71. doi: 10.1021/acsnano.5b03184. Epub 2015 Aug 21. Review.

PMID:
26256227
17.

Protein bio-corona: critical issue in immune nanotoxicology.

Neagu M, Piperigkou Z, Karamanou K, Engin AB, Docea AO, Constantin C, Negrei C, Nikitovic D, Tsatsakis A.

Arch Toxicol. 2017 Mar;91(3):1031-1048. doi: 10.1007/s00204-016-1797-5. Epub 2016 Jul 20. Review.

18.

Characterization of nanoparticles for therapeutics.

Hall JB, Dobrovolskaia MA, Patri AK, McNeil SE.

Nanomedicine (Lond). 2007 Dec;2(6):789-803. Review.

PMID:
18095846
19.

Disposition of nanoparticle-based delivery system via inner ear administration.

Chen G, Zhang X, Yang F, Mu L.

Curr Drug Metab. 2010 Dec;11(10):886-97. Review.

PMID:
21208174
20.

In vivo biodistribution of nanoparticles.

Almeida JP, Chen AL, Foster A, Drezek R.

Nanomedicine (Lond). 2011 Jul;6(5):815-35. doi: 10.2217/nnm.11.79. Review.

PMID:
21793674

Supplemental Content

Support Center